Approval · Notice of Compliance 146 · 2004
UNITRON PEG: Notice of Compliance 146
Issued January 29, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 146
- Date
- January 29, 2004
- Company
- Schering Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New redipen delivery system
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| UNITRON PEG | 02248981 | — |
| UNITRON PEG | 02248982 | — |
| UNITRON PEG | 02248983 | — |
| UNITRON PEG | 02248984 | — |
| UNITRON PEG | 02248985 | — |
Medicinal ingredients
- PEGINTERFERON ALFA-2B 67.5 MCG per CART
- PEGINTERFERON ALFA-2B 108 MCG per CART
- PEGINTERFERON ALFA-2B 135 MCG per CART
- PEGINTERFERON ALFA-2B 162 MCG per CART
- PEGINTERFERON ALFA-2B 202.5 MCG per CART